India: The Pharmacy to the World
ndia is globally recognized as the Pharmacy to the World, supplying affordable, high-quality medicines to patients in more than 200 countries. This leadership is built on a robust manufacturing ecosystem, a highly skilled scientific workforce, and strong compliance with international regulatory standards.
The world witnessed the true scale of India’s pharmaceutical capabilities during the COVID-19 pandemic. While ensuring stable domestic supply, Indian companies also played a critical global role—manufacturing nearly 60% of the world’s vaccines and supporting more than 100 countries through the Vaccine Maitri initiative at a time of limited global access.
Despite major supply chain disruptions, India’s pharmaceutical exports crossed US$24 billion in 2020–21, with essential drugs such as hydroxychloroquine and paracetamol supplied to over 150 nations. Today, India accounts for nearly 20% of the global generic medicine supply, reinforcing its indispensable role in healthcare systems worldwide.
At IndogenMed, we take pride in being part of this powerful ecosystem—providing safe, reliable, and affordable medications that make healthcare accessible for people across the globe.
Why Indian Medicines Are More Affordable
Indian pharmaceutical companies provide high-quality medicines at significantly lower prices compared to many international markets. This affordability is the result of several structural advantages:
1. Patent Expiry & Generic Manufacturing
When patents on branded drugs expire (typically after 20 years), licensed manufacturers can legally produce generic versions. These generics contain the same active ingredient, dosage, strength, and therapeutic effect as the branded drug—but are sold at much lower prices.
2. Economies of Scale
India has one of the world’s largest pharmaceutical manufacturing networks:
• 10,500+ manufacturing units
• 3,000+ USFDA-compliant facilities
High-volume production allows Indian companies to achieve 30–35% lower manufacturing costs than regions like the US or Europe. These cost efficiencies are passed on to patients through affordable pricing.
India supplies:
• 40% of the generic medicines used in the US
• 25% of all medicines prescribed in the UK
3. Lower Marketing Costs
Unlike branded medicines—where significant resources are spent on advertising, doctor outreach, and promotions—generic drug manufacturers focus primarily on production, quality, and distribution.
The result:
Lower marketing expenses = Lower prices for patients, without compromising on efficacy.
4. Strong Regulatory Compliance
Many Indian pharmaceutical companies are certified by leading global authorities:
• WHO-GMP
• USFDA
• EMA (European Medicines Agency)
These certifications ensure Indian medicines meet stringent global quality and safety benchmarks.
5. Skilled Workforce at a Lower Cost
India’s pharmaceutical sector benefits from a large pool of skilled pharmacists, scientists, chemists, and engineers. While the expertise matches global standards, the cost of employing this talent is significantly lower than in western countries. This reduces production and research costs without impacting quality.
6. Innovation in Manufacturing & Supply Chains
Indian pharma companies continue to invest in:
• Advanced manufacturing technologies
• Process optimization
• Efficient supply chains
• Cost-saving innovations
These advancements ensure steady availability and affordability—even during global crises like the COVID-19 pandemic.
Understanding Patents in Medicines
Patent Protection
A pharmaceutical company that develops a new drug receives a patent granting exclusive rights for around 20 years. This period helps recover investment in R&D and clinical trials.
After Patent Expiry
Once the patent expires, approved manufacturers can legally produce generic equivalents.
Impact on Pricing
More manufacturers entering the market increases competition—driving prices down and improving access for patients worldwide.
Why Choose Indian Pharmacies
Indian pharmacies—and platforms like IndogenMed—are trusted globally due to their consistent commitment to quality, compliance, and affordability.
Global Reach
India exports medicines to over 200 countries, with pharma exports reaching US$30.5 billion in FY 2024–25.
Unmatched Regulatory Strength
India has the largest number of USFDA-approved plants outside the United States, along with nearly 1,400 WHO-GMP certified facilities.
World’s Largest Generic Medicine Range
Across 60 therapeutic areas, India offers:
• 60,000+ generic brands
• 20% of the world’s generic drug supply
• 40% of generics used in the US
• 25% of medicines used in the UK
Innovative & Evolving
India is the world’s 3rd-largest pharma producer by volume and continues expanding into biosimilars, complex generics, and patient-friendly formulations—strengthening its global reputation for innovation.
A Responsible Approach
While India’s pharmaceutical industry has made healthcare accessible to millions, responsible use of medicines remains essential.
At IndogenMed, we supply medications strictly for personal use, ensuring full compliance with international regulations, ethical standards, and patient safety protocols.
Our goal is simple:
To make safe, reliable, and affordable medicines accessible to everyone—responsibly and ethically.